Metformin attenuates hepatic insulin resistance in type-2 diabetic rats through PI3K/Akt/GLUT-4 signalling independent to bicuculline-sensitive GABAA receptor stimulation.
about
Autophagy and its link to type II diabetes mellitusMetformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model.Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway.
P2860
Metformin attenuates hepatic insulin resistance in type-2 diabetic rats through PI3K/Akt/GLUT-4 signalling independent to bicuculline-sensitive GABAA receptor stimulation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@en
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@nl
type
label
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@en
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@nl
prefLabel
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@en
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@nl
P2860
P1476
Metformin attenuates hepatic i ...... ve GABAA receptor stimulation.
@en
P2093
Debapriya Garabadu
Sairam Krishnamurthy
P2860
P304
P356
10.1080/13880209.2016.1268635
P577
2017-12-01T00:00:00Z